首页> 美国卫生研究院文献>World Journal of Gastroenterology >Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice
【2h】

Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice

机译:热休克蛋白gp96及其N端片段增强小鼠对HBsAg的体液免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: Most studies on the immune effect of gp96 were focused on its enhancement of CTLs. It is interesting to know whether gp96 could influence the humoral immune response, and whether the recombinant N-terminal fragment of gp96 could substitute native gp96 to stimulate the immune system.METHODS: gp96 isolated from livers of normal mice and its N-terminal fragment (amino acid 22-355) expressed in E coli were used for immunization of BALb/c mice. Eight groups of mice received one of the following regiments subcutaneously in 100 μL phosphate buffered saline (PBS) at an interval of 3 wk. Group 1: PBS only; group 2: gp96 only; group 3: N-terminal fragment only; group 4: HBsAg only; group 5: HBsAg+gp96; group 6: HBsAg+N-terminal fragment; group 7: HBsAg+incomplete Freud’s adjuvant; group 8: HBsAg+N-terminal fragment (95 °C heated for 30 min). Serum anti-HBsAg antibody levels were assayed by ELISA. CTL responses in splenocytes were analyzed by ELISPOT after the last vaccination.RESULTS: The average titer of serum anti-HBsAg antibody in the mice immunized with HBsAg together with gp96 or its N-terminal fragment were much higher than those immunized with HBsAg alone detected by ELISA. The cellular immune response of the mice immunized with HBsAg together with gp96 or its N-terminal fragment was not different with those immunized with HBsAg alone measured by ELISPOT assay.CONCLUSION: gp96 or its N-terminal fragment greatly improved humoral immune response induced by HBsAg, but failed to enhance the CTL response, which demonstrated the potential of using gp96 or its N-terminal fragment as a possible adjuvant to augment humoral immune response against HBV infection.
机译:目的:关于gp96免疫作用的大多数研究都集中在增强CTL上。有趣的是,gp96是否可以影响体液免疫反应,gp96的重组N末端片段是否可以替代天然gp96来刺激免疫系统。方法:从正常小鼠肝脏分离的gp96及其N末端片段(在大肠杆菌中表达的氨基酸(22-355位氨基酸)用于BALb / c小鼠的免疫。八组小鼠以3周间隔在100μL磷酸盐缓冲盐水(PBS)中皮下接受以下方案之一。第1组:仅PBS;组2:仅限gp96;第3组:仅N末端片段;第4组:仅HBsAg;第5组:HBsAg + gp96;第6组:HBsAg + N末端片段;第7组:HBsAg +弗洛伊德不完全佐剂;第8组:HBsAg + N末端片段(95°C加热30分钟)。通过ELISA测定血清抗HBsAg抗体水平。结果:最后一次接种HBsAg和gp96或其N末端片段的小鼠血清抗HBsAg抗体的平均滴度比单独免疫HBsAg的小鼠高得多。 ELISA。结论:gp96或其N末端片段能显着改善HBsAg诱导的体液免疫反应,而HBsAg及其gp96或其N末端片段免疫的小鼠的细胞免疫反应与单独的HBsAg免疫的小鼠无差异。 ,但未能增强CTL反应,这表明使用gp96或其N端片段作为可能的佐剂来增强针对HBV感染的体液免疫反应的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号